Human rights & intellectual property for universal access to new essential medicines

Katrina Perehudoff, Elisabeth 't Hoen

    OnderzoeksoutputAcademic

    Samenvatting

    This chapter illustrates how human rights principles can help governments, even those with the most modest budgets, scale-up universal access to expensive essential medicines. The key message is that governments have legally binding human rights obligations to immediately take steps to provide essential medicines. These steps include making a maximum of public resources available to finance essential medicines, particularly for vulnerable and marginalized groups, and using those resources efficiently. Crucially, using mechanisms to control medicines prices and, in the case of high priced patented medicines, the use of TRIPS flexibilities, is aligned with governments’ duties under human rights law to ensure access to essential medicines. Moreover, the right to health imposes duties on the international community of States and the pharmaceutical industry to respect and protect access to essential medicines.
    Originele taal-2English
    TitelEquitable Access to High-Cost Pharmaceuticals
    RedacteurenZaheer Babar
    UitgeverijElsevier
    StatusPublished - 1-apr-2018

    Citeer dit